The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials.

MLA

Takase-Minegishi, Kaoru, et al. “The Impact of Autoantibodies on the Efficacy of Biological Disease-Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis: Meta-Analysis of Randomized Controlled Trials.” Rheumatology (Oxford, England), Feb. 2024. EBSCOhost, https://doi.org/10.1093/rheumatology/keae113.

APA

Takase-Minegishi, K., Böhringer, S., Nam, J. L., Kaneko, Y., Behrens, F., Saevarsdottir, S., Detert, J., Leirisalo-Repo, M., van der Heijde, D., Landewé, R., Ramiro, S., & van der Woude, D. (2024). The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keae113

Chicago

Takase-Minegishi, Kaoru, Stefan Böhringer, Jackie L Nam, Yuko Kaneko, Frank Behrens, Saedis Saevarsdottir, Jacqueline Detert, et al. 2024. “The Impact of Autoantibodies on the Efficacy of Biological Disease-Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis: Meta-Analysis of Randomized Controlled Trials.” Rheumatology (Oxford, England), February. doi:10.1093/rheumatology/keae113.